A detailed history of Ae Wealth Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ae Wealth Management LLC holds 1,136 shares of VRTX stock, worth $512,301. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,136
Previous 1,167 2.66%
Holding current value
$512,301
Previous $546,000 3.3%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $14,260 - $15,679
-31 Reduced 2.66%
1,136 $528,000
Q2 2024

Aug 12, 2024

SELL
$392.81 - $485.53 $65,206 - $80,597
-166 Reduced 12.45%
1,167 $546,000
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $8.67 Million - $9.49 Million
-21,275 Reduced 94.1%
1,333 $557,000
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $586,530 - $702,262
1,710 Added 8.18%
22,608 $9.2 Million
Q3 2023

Oct 11, 2023

BUY
$338.18 - $362.46 $1.47 Million - $1.58 Million
4,351 Added 26.29%
20,898 $7.27 Million
Q2 2023

Jul 10, 2023

BUY
$314.42 - $351.91 $4.63 Million - $5.18 Million
14,732 Added 811.68%
16,547 $5.82 Million
Q1 2023

Apr 14, 2023

SELL
$283.23 - $323.1 $900,954 - $1.03 Million
-3,181 Reduced 63.67%
1,815 $571,000
Q4 2022

Jan 31, 2023

BUY
$285.76 - $321.48 $1.02 Million - $1.14 Million
3,552 Added 245.98%
4,996 $1.44 Million
Q3 2022

Oct 25, 2022

BUY
$273.83 - $305.53 $62,159 - $69,355
227 Added 18.65%
1,444 $418,000
Q2 2022

Aug 03, 2022

BUY
$234.96 - $292.55 $63,674 - $79,281
271 Added 28.65%
1,217 $343,000
Q1 2022

Apr 18, 2022

BUY
$221.42 - $260.97 $209,463 - $246,877
946 New
946 $247,000
Q3 2021

Nov 01, 2021

SELL
$181.39 - $202.99 $186,287 - $208,470
-1,027 Closed
0 $0
Q2 2021

Jul 21, 2021

SELL
$187.49 - $221.1 $2.21 Million - $2.61 Million
-11,804 Reduced 92.0%
1,027 $207,000
Q1 2021

Apr 27, 2021

BUY
$207.02 - $241.31 $2.44 Million - $2.84 Million
11,782 Added 1123.16%
12,831 $2.76 Million
Q4 2020

Feb 01, 2021

SELL
$207.01 - $276.09 $694,518 - $926,281
-3,355 Reduced 76.18%
1,049 $248,000
Q3 2020

Nov 06, 2020

BUY
$255.65 - $303.1 $539,677 - $639,844
2,111 Added 92.06%
4,404 $1.2 Million
Q2 2020

Aug 05, 2020

SELL
$225.48 - $295.8 $404,736 - $530,961
-1,795 Reduced 43.91%
2,293 $666,000
Q1 2020

May 07, 2020

BUY
$199.77 - $247.81 $464,265 - $575,910
2,324 Added 131.75%
4,088 $973,000
Q4 2019

Jan 15, 2020

BUY
$166.71 - $223.91 $294,076 - $394,977
1,764 New
1,764 $386,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.